Neogen Corporation $NEOG Shares Bought by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in Neogen Corporation (NASDAQ:NEOG) by 250.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,490,800 shares of the company’s stock after acquiring an additional 2,493,900 shares during the period. Healthcare of Ontario Pension Plan Trust Fund owned approximately 1.60% of Neogen worth $24,401,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. UMB Bank n.a. raised its stake in shares of Neogen by 238.2% during the fourth quarter. UMB Bank n.a. now owns 6,422 shares of the company’s stock valued at $45,000 after purchasing an additional 4,523 shares during the period. Hantz Financial Services Inc. raised its stake in shares of Neogen by 816.9% during the fourth quarter. Hantz Financial Services Inc. now owns 7,592 shares of the company’s stock valued at $53,000 after purchasing an additional 6,764 shares during the period. Cresset Asset Management LLC purchased a new stake in shares of Neogen during the second quarter valued at approximately $53,000. Evergreen Capital Management LLC purchased a new stake in shares of Neogen during the second quarter valued at approximately $56,000. Finally, Northwestern Mutual Wealth Management Co. raised its stake in shares of Neogen by 3,158.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 8,309 shares of the company’s stock valued at $58,000 after purchasing an additional 8,054 shares during the period. Institutional investors and hedge funds own 96.73% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Neogen in a research note on Friday, April 10th. Finally, William Blair reiterated a “market perform” rating on shares of Neogen in a research note on Monday, March 2nd. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Neogen has a consensus rating of “Hold” and an average target price of $10.67.

Neogen Stock Up 2.2%

Shares of NASDAQ:NEOG opened at $9.30 on Tuesday. The firm has a market cap of $2.02 billion, a PE ratio of -3.32, a price-to-earnings-growth ratio of 4.07 and a beta of 1.81. The company has a fifty day simple moving average of $9.17 and a 200 day simple moving average of $9.00. The company has a current ratio of 3.92, a quick ratio of 2.84 and a debt-to-equity ratio of 0.38. Neogen Corporation has a 12-month low of $4.56 and a 12-month high of $11.43.

Neogen (NASDAQ:NEOG) last released its quarterly earnings data on Thursday, April 9th. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.05. The firm had revenue of $211.20 million during the quarter, compared to the consensus estimate of $204.62 million. Neogen had a negative net margin of 69.93% and a positive return on equity of 2.35%. The business’s quarterly revenue was down 4.4% on a year-over-year basis. On average, equities research analysts anticipate that Neogen Corporation will post 0.23 EPS for the current fiscal year.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.